Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Astera Labs (ALAB) EBT Margin (2023 - 2025)

Astera Labs (ALAB) has disclosed EBT Margin for 3 consecutive years, with 29.16% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 2158.0% year-over-year to 29.16%, compared with a TTM value of 25.59% through Dec 2025, up 4622.0%, and an annual FY2025 reading of 25.59%, up 4622.0% over the prior year.
  • EBT Margin was 29.16% for Q4 2025 at Astera Labs, up from 29.0% in the prior quarter.
  • Across five years, EBT Margin topped out at 29.16% in Q4 2025 and bottomed at 150.24% in Q2 2023.
  • Average EBT Margin over 3 years is 21.82%, with a median of 4.68% recorded in 2024.
  • The sharpest move saw EBT Margin tumbled -2511bps in 2024, then surged 13684bps in 2025.
  • Year by year, EBT Margin stood at 21.17% in 2023, then tumbled by -64bps to 7.58% in 2024, then skyrocketed by 285bps to 29.16% in 2025.
  • Business Quant data shows EBT Margin for ALAB at 29.16% in Q4 2025, 29.0% in Q3 2025, and 26.4% in Q2 2025.